Manufacturer of Controlled Substances; Notice of Registration; Pharmagra Labs, Inc., 33443 [2013-13227]
Download as PDF
<![CDATA[
33443
Federal Register / Vol. 78, No. 107 / Tuesday, June 4, 2013 / Notices
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic class of
controlled substance listed.
Dated: May 24, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–13230 Filed 6–3–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Pharmagra Labs, Inc.
By Notice dated February 8, 2013, and
published in the Federal Register on
February 21, 2013, 78 FR 12102,
Pharmagra Labs, Inc., 158 McLean Road,
Brevard, North Carolina 28712, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Pentobarbital (2270), a basic class of
controlled substance in schedule II.
The company plans to manufacture
the listed substance for analytical
research and clinical trials.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of
Pharmagra Labs, Inc., to manufacture
the listed basic class of controlled
substance is consistent with the public
interest at this time. DEA has
investigated Pharmagra Labs., Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic class of
controlled substance listed.
Dated: May 24, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–13227 Filed 6–3–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Alltech Associates, Inc.
By Notice dated February 8, 2013 and
published in the Federal Register on
February 21, 2013, 78 FR 12103, Alltech
Associates, Inc., 2051 Waukegan Road,
Deerfield, Illinois 60015, made
application to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Drug
Schedule
tkelley on DSK3SPTVN1PROD with NOTICES
5-Methoxy-N-N-dimethyltryptamine (7431) .................................................................................................................................................
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine) (7509) .......................................................................................................................
2C-H (2-(2,5-Dimethoxyphenyl)ethanamine) (7517) ...................................................................................................................................
2C-T-4 (2-(4-isopropylthio)-2,5-dimethoxyphenyl) ethanamine) (7532) ......................................................................................................
The company plans to manufacture
high purity drug standards used for
analytical applications only in clinical,
toxicological, and forensic laboratories.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Alltech Associates, Inc., to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Alltech Associates, Inc., to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: May 24, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
18:33 Jun 03, 2013
Jkt 229001
Methamphetamine (1105) ............
Pentobarbital (2270) .....................
Nabilone (7379) ............................
Schedule
II
II
II
[FR Doc. 2013–13228 Filed 6–3–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Norac, Inc.
By Notice dated November 19, 2012,
and published in the Federal Register
on November 27, 2012, 77 FR 70825,
Norac, Inc., DBA: Norac Pharma, 405 S.
Motor Avenue, Azusa, California
91702–3232, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Drug
Schedule
Gamma
Hydroxybutyric
Acid
(2010).
Tetrahydrocannabinols (7370) .....
VerDate Mar<15>2010
Drug
I
I
I
I
PO 00000
Frm 00119
Fmt 4703
Sfmt 4703
I
I
With regard to Gamma
Hydroxybutyric Acid (2010),
Tetrahydrocannabinols (7370), and
Methamphetamine (1105) only, the
company manufactures these controlled
substances in bulk solely for domestic
distribution within the United States to
customers engaged in dosage-form
manufacturing.
With regard to Nabilone (7379) only,
the company presently manufactures a
small amount of this controlled
substance in bulk solely to conduct
manufacturing internal process
development. It is the company’s
intention once the manufacturing
process is refined to the point that its
Nabilone bulk product is available for
commercial use, the company will
export the controlled substance in bulk
solely to customers engaged in dosageform manufacturing outside the United
States. The company is aware of the
requirement to obtain a DEA registration
as an exporter to conduct this activity.
E:\FR\FM\04JNN1.SGM
04JNN1
]]>Agencies
[Federal Register Volume 78, Number 107 (Tuesday, June 4, 2013)]
[Notices]
[Page 33443]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-13227]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Pharmagra Labs, Inc.
By Notice dated February 8, 2013, and published in the Federal
Register on February 21, 2013, 78 FR 12102, Pharmagra Labs, Inc., 158
McLean Road, Brevard, North Carolina 28712, made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of Pentobarbital (2270), a basic class of controlled
substance in schedule II.
The company plans to manufacture the listed substance for
analytical research and clinical trials.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a), and determined that the registration
of Pharmagra Labs, Inc., to manufacture the listed basic class of
controlled substance is consistent with the public interest at this
time. DEA has investigated Pharmagra Labs., Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic class of controlled substance listed.
Dated: May 24, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-13227 Filed 6-3-13; 8:45 am]
BILLING CODE 4410-09-P
